Knee osteoarthritis (OA) is a disabling joint condition that leads to extreme mobility and quality of life impairment, particularly among older adults. This study aimed to investigate the socio-demographic factors and comorbid conditions influencing the severity of symptoms of knee OA using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Data were derived from 622 patients across 9 months from the major healthcare facilities of Dhaka. Age, sex, educational status, obesity, diabetes mellitus, and cardiovascular disease (CVD) were predictors for the severity of symptoms of OA of the knee, the study claimed. Female participants were more prone to have severe symptoms compared to males, and those who were more than 70-years-old were at greater risk of severe symptoms. Low educational status, obesity, diabetes mellitus, and CVD were also predictors for severe OA of the knee. Age (p<0.001), obesity (p<0.001), and diabetes (p<0.001) were the best predictors of severity of symptoms based on the multinomial logistic regression analysis. The findings from the study highlight the complex etiology of OA of the knee and the need for integral healthcare measures that address both the socio-economic and the physical determinants. Focused interventions need to be employed, particularly for high-risk groups such as the elderly, women, and the comorbid, to minimize the incidence of OA of the knee and maximize the outcomes for patients in settings such as that of Bangladesh, where resources may not be available.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for this study was obtained from the Institutional Review Board (IRB) of the National Institute of Traumatology and Orthopaedic Rehabilitation (NITOR/PT/93/lRB/2024/02). Informed consent was obtained from all participants prior to their inclusion in the study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Email: kekakarimyahoo.com (MK), delwar3497gmail.com (MDH), tasrimatrishagmail.com (TTR), drfatemaarzumanpriyankagmail.com (FP), rahnumatwasingmail.com (RHT), dr.ilat86gmail.com, drummesalma785gmail.com, 4abedingmail.com (JAI), marzanaafroozgmail.com (MAR)

All data produced in the present study are available upon reasonable request to the authors